Peptidream Inc., of Tokyo, inked a multitarget discovery and optimization collaboration with Merck & Co. Inc., of Kenilworth, N.J. Peptidream will use its Peptide Discovery Platform System (PDPS) technology to generate macrocylic/constrained peptides against multiple targets of interest selected by Merck.